1. Introduction {#sec1}
===============

The increasing prevalence of obesity is a global health concern. In 2005, an estimated 400 million adults worldwide were obese \[[@B1]\].

Obesity increases the risk of type 2 diabetes, hypertension, heart disease, stroke, dyslipidemia, osteoarthritis, gynecological problems, sleep apnea, and respiratory problems. In addition, studies have reported that obesity has an adverse effect on iron status \[[@B2]--[@B6]\]. Studies on obese mice showed high level of hepatic hepcidin mRNA expression and suggested that lower hepatic iron status in obese animals might be associated with inflammation. Hepcidin is a homeostatic regulator of iron metabolism that restricts intestinal iron absorption and is known as a mediator of inflammation \[[@B7]\]. Rapid dietary and lifestyle changes in Mexico have produced a double burden of malnutrition with under- and over-nutrition occurring in the same population \[[@B8]\].

Obesity is characterized by chronic, low-grade, systemic inflammation, which, in turn, has been associated with anemia of chronic disease specifically, elevated serum ferritin and low serum iron, transferrin saturation (TS), and hemoglobin. Studies have shown that the CRP concentration decreases significantly after massive weight reduction. This decrease indicates that fat mass plays an important role in the production of CRP. CRP is the main acute phase protein and it is also a sensitive marker of systemic inflammation \[[@B9]\]. A large study confirmed that overweight children were twice as likely to be iron deficient as normal weight children \[[@B10]\]. Ausk and coworker showed that increasing BMI is associated with higher serum ferritin levels and lower serum levels of iron and transferrin saturation. However, hemoglobin concentration was not lower in overweight and obese persons compared with normal-weight persons \[[@B11]\].

Another study conducted among 740 school children in Iran showed that prevalence of iron deficiency increased with the subject\'s body mass index \[[@B12]\].

Therefore, we examined the association of body mass index with hemoglobin concentration and iron parameters in adult populations in Yazd province of Iran. We hypothesized that overweight and obese adults have lower iron status than their normal weight counterparts do and that this would be associated with obesity-related inflammation.

2. Materials and Methods {#sec2}
========================

This was a descriptive cross-sectional study conducted among 406 adult patients (18--65 years old) who came to the obesity clinic of yazd diabetes research center in Yazd province (Iran) from January 2011 to January 2013.

The exclusion criteria for this study were conditions that could influence body iron store such as clinical evidence of hemorrhage in the preceding six months, iron or folate or vitamin B12 treatment in the previous year, blood donation within the previous six months, Concomitant Infections, chronic diseases, and diabetes mellitus. Also, persons who were on specific regimen were excluded.

Anthropometric measurements, including height which was measured without shoes against a wall-fixed tape and weight which was measured with light clothing and without shoes on a platform scale with a 1.0 kg subtraction to correct for the weight of the clothing, were taken.

The body mass index (BMI) was calculated as weight/height^2^ (kg/m^2^). For adults, overweight and overall obesity were defined as 25 ≤ BMI \< 30 and BMI ≥ 30, respectively, according to the latest World Health Organization (WHO) criteria \[[@B13]\].

Informed written consent was obtained from all participants, and the study was approved by the hospital\'s human ethics committee. All laboratory measurements were performed on fasting blood samples. Ferritin was measured by a turbidimetric fixed rate method. Serum iron was measured by a photometric color test for clinical chemistry analyzers. transferrin was measured by a turbidimetric end-point method. transferrin saturation index was calculated as serum iron divided by transferrin. Comparisons between groups were performed using analysis of variance and Student\'s *t*-tests for continuous variables and Chi-square test for categorical variables. The relationships between the continuous variables were examined by Pearson\'s linear correlation test. Significance was accepted at the level of *P* ≤ 0.05. All statistical procedures were performed by using SPSS 16.0 for Windows (SPSS Inc., Chicago, IL).

3. Results {#sec3}
==========

In this cross-sectional study, we collected data from 406 persons (18--65 years old) that were referred to the obesity clinic of Yazd diabetes research center in Yazd province in Iran from January 2012 to January 2013. In this study, were %22.1 male (90 patients) and were %77.9 female (316 patients).

Demographic characteristics, anthropometric measurements, and biochemical indexes by BMI categories are shown in [Table 1](#tab1){ref-type="table"}. In this study, 32.2% of total was normal weight and 37.7% and 30.1% were overweight and obese, respectively. No difference in hemoglobin concentrations, MCV, serum iron, TIBC, transferrin saturation index, and ferritin was found between all BMI groups ([Table 1](#tab1){ref-type="table"}).

4. Discussion {#sec4}
=============

Obesity is a risk factor for many diseases such as type 2 diabetes, hypertension, heart disease, stroke, dyslipidemia, osteoarthritis, gynecological problems, sleep apnea, and respiratory problems. Also, studies showed that obesity has an adverse effect on iron status \[[@B2]--[@B6]\].

The results of our study showed that BMI had no correlation with hemoglobin, MCV, serum iron, TIBC, transferrin saturation index, and ferritin. This result is against the previous results that were mentioned \[[@B9]--[@B12]\].

Obesity was diagnosed in 16.7% of children in the study by Sharma and coworkers. Children with high BMI group had significantly lower serum iron levels and markedly higher CRP and soluble transferrin receptor levels. Serum iron exhibited a significant correlation with both the BMI and CRP. Ferritin concentration was similar in the group of obese as well as normal weight children \[[@B14]\]. Lower levels of serum iron and transferrin saturation have been observed in obese adults compared to nonobese matched controls, with fat mass shown to be a significant negative predictor of serum iron concentration \[[@B15]\].

The cause of the iron deficiency of obesity is unclear. Iron deficiency in obese individuals may be a result of low iron intake (due to an unbalanced diet), reduced iron absorption in the small intestine, and greater iron requirements caused by a larger blood volume. In addition, obesity is associated with a chronic low grade inflammation state. For this reason, sequestration of iron through an inflammatory mediated mechanism can be one of the proposed causes of iron deficiency in obesity \[[@B15], [@B16]\].

We exclude diabetic patients in our study. Lecube and coworker showed that, in postmenopausal women with obesity, serum ferritin levels were significantly higher in obese women with metabolic syndrome in comparison with obese women without metabolic syndrome. There is no difference in the other markers of iron status such as iron, soluble transferrin receptor, transferrin, and transferrin saturation index. Diabetic patients had higher ferritin levels than nondiabetic patients. Nondiabetic patients with metabolic syndrome also showed higher ferritin levels than nondiabetic patients without metabolic syndrome. Among the components of metabolic syndrome, only diabetes was independently associated with serum ferritin levels in both the whole group and in patients with metabolic syndrome \[[@B17]\]. These findings may be explained in our results (exclusion of diabetic patients). It seems that diabetes had a powerful predictor for inflammation and anemia of chronic disease rather than for obesity itself.

Another cause of our finding (normal markers of iron status in obese persons) may be well nutritional status of obese people, for example, intake of high iron foods.

The main limitation of our study is the use of limited laboratory indexes such as iron, transferrin, and ferritin which were selected because they are readily available in many biochemical tests. Other inflammatory parameters such as CRP, interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-alpha) should be studied as well in the future. Also studies with greater sample size are recommended.

5. Conclusions {#sec5}
==============

BMI had no correlation with hemoglobin, MCV, serum iron, TIBC, transferrin saturation index, and ferritin. Nutritional status of persons and intake of high iron foods by obese persons should be considered. Also other inflammatory markers should be evaluated in the future studies.
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###### 

Baseline characteristics of patients according to BMI.

  ----------------------------------------------------------------------------------------------------------------
  Variable               Normal weight\       Overweight\          Obese\               Total\         *P* value
                         (*n* = 131; 32.2%)   (*n* = 153; 37.7%)   (*n* = 122; 30.1%)   (406, 100%)    
  ---------------------- -------------------- -------------------- -------------------- -------------- -----------
  Age (y)                34 ± 13              42.9 ± 13.4          43.9 ± 12            40.6 ± 13.9    0.001

  BMI (kg/m^2^)          21.76 ± 2.8          27.8 ± 1.4           35.3 ± 5.9           28.1 ± 6.5     0.001

  Hemoglobin (mg/dL)     13.2 ± 1.4           13.7 ± 6.3           13.5 ± 1.2           13.5 ± 4       0.58

  MCV                    84.6 ± 8.4           83.3 ± 8.5           84.3 ± 7.9           84.1 ± 8.3     0.38

  Serum iron (*μ*g/dL)   81.9 ± 32.3          76 ± 27.7            79.8 ± 29            79.1 ± 29.7    0.27

  TIBC (*μ*g/dL)         327 ± 51             343 ± 48             334 ± 66.2           335.6 ± 55.7   0.06

  TS (%)                 26.9 ± 20.4          22.7 ± 8.7           26.2 ± 20.6          25.15 ± 17.1   0.08

  Ferritin (ng/mL)       88 ± 40              76.8 ± 43            82.2 ± 53            82.1 ± 51      0.53
  ----------------------------------------------------------------------------------------------------------------
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